Drug intelligence / Profile preview

artificial cerebrospinal fluid (Otsuka Holdings)

Development stage
Unknown
Lead developer
Otsuka Pharmaceutical Factory, Inc.
Modality
Small Molecules
Administration
Intrathecal, Parenteral
01

Overview

Artcereb is an artificial cerebrospinal fluid (CSF) solution developed to closely match the electrolyte composition, pH, and osmotic pressure of natural human CSF. It is primarily indicated as an irrigation and perfusion solution during neurosurgical procedures to prevent tissue damage, maintain intracranial pressure, and provide a physiological environment for the brain and spinal cord. Beyond its surgical use, Artcereb is being investigated as a diagnostic tool in the CSF refill test for patients suspected of having cerebrospinal fluid hypovolemia. In this application, the solution is injected intrathecally to evaluate symptomatic relief and changes in CSF pressure, aiding in the diagnosis of orthostatic headaches associated with low CSF volume.

Brand names
Artcereb
Other names
Artcereb Irrigation and Perfusion Solution for Neurosurgery

Beyond the preview

Go deeper on artificial cerebrospinal fluid (Otsuka Holdings).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on artificial cerebrospinal fluid (Otsuka Holdings).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call